An office based focal therapy to treat prostate cancer while preserving quality of life
1 in 8 men will develop prostate cancer
- Prostate cancer is the most common internal cancer in men, with most localized within the gland.
- 50% of patients treated with existing therapies lose their sexual or urinary function.
- At Avenda Health, we believe patients should not choose between treating their prostate cancer and maintaining their quality of life.
Our Technology is Backed By Science
- Our technology is based on nearly a decade of research funded by the National Cancer Institute.
- Imaging and biopsy information from thousands of patients are leveraged to identify an individual’s unique cancer margin.
- We reimagined laser ablation — used in many types of cancer therapy — to create a simple office-based tissue ablation procedure for prostate cancer.
The Orion System
The Orion System* delivers targeted treatment through focal laser ablation, minimizing the impact to healthy tissue and preserving urinary and sexual function. Tissue temperature and treatment progress can be monitored in real-time.
A laser needle and sensor are inserted into the target tissue under ultrasound guidance. The laser needle gently heats tissue causing coagulation necrosis. Requiring only local anesthesia, patients experience minimal to no downtime.
*Investigational and not approved by the FDA. Not for sale